IXSBF (InNexus Biotechnology) Scaled Net Operating Assets : 0.08 (As of Mar. 2011)

View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

InNexus Biotechnology's operating assets for the quarter that ended in Mar. 2011 was $3.21 Mil. InNexus Biotechnology's operating liabilities for the quarter that ended in Mar. 2011 was $2.93 Mil. InNexus Biotechnology's Total Assets for the quarter that ended in Dec. 2010 was $3.31 Mil. Therefore, InNexus Biotechnology's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2011 was 0.08.

InNexus Biotechnology Scaled Net Operating Assets Historical Data

The historical data trend for InNexus Biotechnology's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology Scaled Net Operating Assets Chart

InNexus Biotechnology Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun06

Jun07

Jun08

Jun09

Jun10

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.84

1.70

0.22

0.08

-0.41

InNexus Biotechnology Quarterly Data
	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.31	-0.43	0.23	0.17	0.08

Competitive Comparison of InNexus Biotechnology's Scaled Net Operating Assets

For the Biotechnology subindustry, InNexus Biotechnology's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InNexus Biotechnology's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InNexus Biotechnology's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where InNexus Biotechnology's Scaled Net Operating Assets falls into.

InNexus Biotechnology Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

InNexus Biotechnology's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2010 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jun. 2010 )
=	(Operating Assets (A: Jun. 2010 )	-	Operating Liabilities (A: Jun. 2010 ))	/	Total Assets (A: Jun. 2009 )
=	(3.312	-	5.013)	/	4.158
=	-0.41

where

	Operating Assets		(A: Jun. 2010 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	3.312	-	0
=	3.312

	Operating Liabilities		(A: Jun. 2010 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	8.255	-	0	-	3.242
=	5.013

InNexus Biotechnology's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2011 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2011 )
=	(Operating Assets (Q: Mar. 2011 )	-	Operating Liabilities (Q: Mar. 2011 ))	/	Total Assets (Q: Dec. 2010 )
=	(3.205	-	2.933)	/	3.313
=	0.08

where

	Operating Assets		(Q: Mar. 2011 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	3.237	-	0.032
=	3.205

	Operating Liabilities		(Q: Mar. 2011 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	9.811	-	0.269	-	6.609
=	2.933

InNexus Biotechnology Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

InNexus Biotechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7

Website

http://www.ixsbio.com

InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology Headlines

No Headlines